Wantstats
Company ProfilePremium

Celgene Corporation

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Celgene Corporation - Healthcare showcase

Year Founded & Workforce

1986

8,852 Employees

Industry

Healthcare

Services

Chemotherapy
C

Celgene Corporation Employee Contacts

3 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Celgene Corporation Overview

Company Headquarters: New Jersey, US

Founded: 1986

Workforce: 8,852

Company Working:

Celgene Corporation is a global leading biopharmaceutical company focused on the development and commercialization of innovative drugs used in the treatment of cancer and inflammatory diseases. The company conducted more than 300 clinical trials for various applications such as multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer, and pancreatic cancer. It has a strong presence in North America, Europe, and Asia.

Strategy

Celgene Corporation focuses on developing a diversified product portfolio by the innovation and development of products, thus delivering integrated solutions to large healthcare customers. It also emphasizes acquisitions and collaborations to enhance its presence in the industry.

Company Snapshot

$11,229M

Revenue

8,852

Employees

1986

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

  • Strong R&D team
  • Strong product portfolio
  • Skilled workforce

Weaknesses

  • Small size and product lines as compared to key players

Opportunities

  • Catering to developing and under developed countries

Threats

  • Strong competition from international key players

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2017CollaborationCelgene Corporation entered into a collaboration with BeiGene to develop and commercialize oncology products.
June 2016CollaborationThe company entered into a collaboration with four National Cancer Institutes for the development of novel cancer therapeutic products.

Product Offering

  • Celgene Corporation
    • Chemotherapy

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 11,229 Mn in 2016 to USD 15,281 Mn in 2018.
Celgene Corporation — By Business Segment
Series (USD Mn)201620172018
Sales11,22913,00315,281
R&D4,4705,9155,673

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →